✦ LIBER ✦

`Synercid' - a novel agent for severe multiresistant Gram-positive infections

Book ID: 120869629
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2000
Weight: 165 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200012270-00025

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Teicoplanin: A New Agent for Gram-Positi

Teicoplanin: A New Agent for Gram-Positive Bacterial Infections

✍ Mark Eggleston and Joseph Ofosu 📂 Article 📅 1988 🏛 University of Chicago Press 🌐 English ⚖ 589 KB

Novel antibacterial agents for the treat

Novel antibacterial agents for the treatment of serious Gram-positive infections

✍ Abbanat, Darren; Macielag, Mark; Bush, Karen 📂 Article 📅 2003 🏛 Informa plc 🌐 English ⚖ 308 KB

Dalbavancin and telavancin: novel lipogl

Dalbavancin and telavancin: novel lipoglycopeptides for the treatment of Gram-positive infections

✍ Zhanel, George G ;Trapp, Shannon ;Gin, Alfred S ;DeCorby, Mel ;Lagacé-Wiens, Phi 📂 Article 📅 2008 🏛 Expert Reviews 🌐 English ⚖ 274 KB

Next Science Wound Gel Technology, a Nov

Next Science Wound Gel Technology, a Novel Agent That Inhibits Biofilm Development by Gram-Positive and Gram-Negative Wound Pathogens

✍ Miller, K. G.; Tran, P. L.; Haley, C. L.; Kruzek, C.; Colmer-Hamood, J. A.; Mynt 📂 Article 📅 2014 🏛 American Society for Microbiology 🌐 English ⚖ 895 KB

Linezolid (ZYVOX), the First Member of a

Linezolid (ZYVOX), the First Member of a Completely New Class of Antibacterial Agents for Treatment of Serious Gram-Positive Infections

✍ Brickner, Steven J.; Barbachyn, Michael R.; Hutchinson, Douglas K.; Manninen, Pe 📂 Article 📅 2008 🏛 American Chemical Society 🌐 English ⚖ 171 KB